BR112022003759A2 - Método e uso de pnpp-19 para prevenção e tratamento de doenças oculares - Google Patents
Método e uso de pnpp-19 para prevenção e tratamento de doenças ocularesInfo
- Publication number
- BR112022003759A2 BR112022003759A2 BR112022003759A BR112022003759A BR112022003759A2 BR 112022003759 A2 BR112022003759 A2 BR 112022003759A2 BR 112022003759 A BR112022003759 A BR 112022003759A BR 112022003759 A BR112022003759 A BR 112022003759A BR 112022003759 A2 BR112022003759 A2 BR 112022003759A2
- Authority
- BR
- Brazil
- Prior art keywords
- pnpp
- treatment
- eye diseases
- prevention
- glaucoma
- Prior art date
Links
- 208000030533 eye disease Diseases 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title abstract 2
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 206010056677 Nerve degeneration Diseases 0.000 abstract 1
- 102000008299 Nitric Oxide Synthase Human genes 0.000 abstract 1
- 108010021487 Nitric Oxide Synthase Proteins 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000001328 optic nerve Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962895252P | 2019-09-03 | 2019-09-03 | |
| US17/008,794 US20210060125A1 (en) | 2019-09-03 | 2020-09-01 | METHOD AND USE OF PnPP-19 FOR PREVENTING AND TREATING EYE DISEASES |
| PCT/BR2020/050349 WO2021042193A1 (en) | 2019-09-03 | 2020-09-01 | Method and use of pnpp-19 for preventing and treating eye diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022003759A2 true BR112022003759A2 (pt) | 2022-05-31 |
Family
ID=74682721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022003759A BR112022003759A2 (pt) | 2019-09-03 | 2020-09-01 | Método e uso de pnpp-19 para prevenção e tratamento de doenças oculares |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210060125A1 (https=) |
| EP (1) | EP4025234A4 (https=) |
| JP (1) | JP2022547231A (https=) |
| KR (1) | KR20220084011A (https=) |
| CN (1) | CN114302734A (https=) |
| BR (1) | BR112022003759A2 (https=) |
| CA (1) | CA3147704A1 (https=) |
| WO (1) | WO2021042193A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024168415A1 (en) * | 2023-02-17 | 2024-08-22 | Biozeus Biopharmaceutical S.A. | Topical peptide formulation for the treatment of sexual dysfunction |
| WO2025133214A1 (en) | 2023-12-21 | 2025-06-26 | Novaliq Gmbh | Ophthalmic polypeptide compositions for the treatment of posterior eye disorders |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005097137A (ja) * | 2003-09-22 | 2005-04-14 | Tokyoto Igaku Kenkyu Kiko | 糖尿病性網膜症の予防又は治療剤 |
| JP2011219412A (ja) * | 2010-04-09 | 2011-11-04 | Saisentan Igaku Kenkyusho:Kk | 緑内障の視野改善治療薬 |
| US8759298B2 (en) * | 2010-05-03 | 2014-06-24 | Scott & White Healthcare | Protein therapy for corneal inflammation, epithelial wound healing, and photoreceptor degeneration |
| MX362058B (es) * | 2012-08-20 | 2019-01-07 | Univ Federal De Minas Gerais Ufmg | Péptido pntx(19) sintético, composición farmacéutica y uso. |
| GB201401453D0 (en) * | 2014-01-28 | 2014-03-12 | Univ Birmingham | Transmucosal and transepithelial drug delivery system |
| BR102014010268B1 (pt) * | 2014-04-29 | 2021-12-28 | Universidade Federal De Minas Gerais - Ufmg | Uso do peptídeo sintético pntx-19 para tratamento de dor |
| WO2017068388A2 (pt) * | 2015-09-18 | 2017-04-27 | Universidade Federal De Minas Gerais - Ufmg | Uso do peptideo sintetico pntx-19 para tratamento de dor |
-
2020
- 2020-09-01 CA CA3147704A patent/CA3147704A1/en active Pending
- 2020-09-01 WO PCT/BR2020/050349 patent/WO2021042193A1/en not_active Ceased
- 2020-09-01 CN CN202080061721.7A patent/CN114302734A/zh active Pending
- 2020-09-01 US US17/008,794 patent/US20210060125A1/en not_active Abandoned
- 2020-09-01 BR BR112022003759A patent/BR112022003759A2/pt unknown
- 2020-09-01 KR KR1020227006863A patent/KR20220084011A/ko not_active Abandoned
- 2020-09-01 EP EP20860001.5A patent/EP4025234A4/en not_active Withdrawn
- 2020-09-01 JP JP2022539453A patent/JP2022547231A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022547231A (ja) | 2022-11-10 |
| US20210060125A1 (en) | 2021-03-04 |
| CN114302734A (zh) | 2022-04-08 |
| CA3147704A1 (en) | 2021-03-11 |
| EP4025234A1 (en) | 2022-07-13 |
| WO2021042193A1 (en) | 2021-03-11 |
| KR20220084011A (ko) | 2022-06-21 |
| EP4025234A4 (en) | 2023-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018014573A (es) | Vacuna contra el virus del zika. | |
| CO2023013050A2 (es) | Composiciones de psilocibina, métodos para prepararlas y métodos de uso de estas | |
| BR112022010112A2 (pt) | Aminoquinolonas substituídas como inibidores de dgkalfa para ativação imunológica | |
| MX2019007586A (es) | Composiciones que comprenden tacrolimus para el tratamiento de enfermedades inflamatorias intraoculares. | |
| MX2021004708A (es) | Metodos y composiciones para tratamiento de presbicia, midriasis y otros trastornos oculares. | |
| CO2020014563A2 (es) | Uso de clorhidrato de pilocarpina para el tratamiento de condiciones oculares | |
| CL2019000935A1 (es) | Composición farmacéutica, métodos para tratamiento y usos de la misma. | |
| BR112018012876A2 (pt) | bisturi oftálmico e métodos de uso | |
| MX2021015853A (es) | Analogos de 3-(5-metil-1,3-tiazol-2-il)-n-{(1r)-1-[2-(trifluor-met il)pirimidin-5-il]etil}benzamida. | |
| CL2021002582A1 (es) | Vacunas contra el circovirus porcino tipo 3 (pcv3), su producción y usos | |
| CL2022002566A1 (es) | Combinaciones de brimonidina de dosis baja y usos de las mismas. (solicitud divisional de 201903572) | |
| BR112022000229A2 (pt) | Composição para uso no tratamento da perda de cabelo | |
| BR112022003759A2 (pt) | Método e uso de pnpp-19 para prevenção e tratamento de doenças oculares | |
| EA201990752A1 (ru) | Офтальмологический состав, содержащий цитиколин, переносимый липосомой, для лечения глаукомы | |
| AR120655A1 (es) | Anticuerpos ampliamente neutralizantes contra vih | |
| MX385405B (es) | Composición inyectable en el vítreo de un ojo que comprende un inhibidor de cinasa y el uso de la misma para tratar una enfermedad ocular. | |
| ECSP21002804A (es) | Apirasas solubilizadas, métodos y usos | |
| MX2020012011A (es) | Conjugados y derivados de prostaglandina para tratar el glaucoma y la hipertension ocular. | |
| DOP2024000117A (es) | Anticuerpos anti-c3 y fragmentos de unión al antígeno de estos y sus usos para tratar enfermedades oftálmicas u oculares | |
| MX2021005910A (es) | Formulacion de proteina de alta concentracion. | |
| MX2017013879A (es) | Composiciones que comprenden anakinra. | |
| CL2022003349A1 (es) | Composiciones de nanoemulsiones oftálmicas | |
| BR112019017314A2 (pt) | composições farmacêuticas para terapia de combinação | |
| MX2021004418A (es) | Derivados de 4 pirazin 2 ilmetil-morfolina y su uso como medicamento. | |
| MX2021013634A (es) | Composiciones estables de albuvirtida. |